Amgen VP-Licensing Scott Foraker: An Interview With “The Pink Sheet” DAILY (Part 2 of 2)
Foraker advises competitors to “watch out” for new Amgen initiatives in Asia “in the coming months.”
Foraker advises competitors to “watch out” for new Amgen initiatives in Asia “in the coming months.”